These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16561427)

  • 21. Tandem repeat regions within the Burkholderia pseudomallei genome and their application for high resolution genotyping.
    U'Ren JM; Schupp JM; Pearson T; Hornstra H; Friedman CL; Smith KL; Daugherty RR; Rhoton SD; Leadem B; Georgia S; Cardon M; Huynh LY; DeShazer D; Harvey SP; Robison R; Gal D; Mayo MJ; Wagner D; Currie BJ; Keim P
    BMC Microbiol; 2007 Mar; 7():23. PubMed ID: 17397553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-level resistance to fluoroquinolones and cephalosporins in Burkholderia pseudomallei and closely related species.
    Viktorov DV; Zakharova IB; Podshivalova MV; Kalinkina EV; Merinova OA; Ageeva NP; Antonov VA; Merinova LK; Alekseev VV
    Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S103-10. PubMed ID: 19121669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Burkholderia pseudomallei animal and human isolates from Malaysia exhibit different phenotypic characteristics.
    Lee SH; Chong CE; Lim BS; Chai SJ; Sam KK; Mohamed R; Nathan S
    Diagn Microbiol Infect Dis; 2007 Jul; 58(3):263-70. PubMed ID: 17350202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA microarray-based detection and identification of Burkholderia mallei, Burkholderia pseudomallei and Burkholderia spp.
    Schmoock G; Ehricht R; Melzer F; Rassbach A; Scholz HC; Neubauer H; Sachse K; Mota RA; Saqib M; Elschner M
    Mol Cell Probes; 2009; 23(3-4):178-87. PubMed ID: 19366627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inactivation of virulent Burkholderia pseudomallei by sunlight.
    Sagripanti JL; Levy A; Robertson J; Merritt A; Inglis TJ
    Photochem Photobiol; 2009; 85(4):978-86. PubMed ID: 19192198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid multiplex immunofluorescent assay to detect antibodies against Burkholderia pseudomallei and taxonomically closely related nonfermenters.
    Iihara H; Niwa T; Shah MM; Nhung PH; Song SX; Hayashi M; Ohkusa K; Itoh Y; Makino S; Ezaki T
    Jpn J Infect Dis; 2007 Jul; 60(4):230-4. PubMed ID: 17642542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cellular fatty acid composition of the Burkholderia mallei and Burkholderia pseudomallei strains as generic feature of Burkholderia].
    Vasiurenko ZP; Sel'nikova OP; Polishchuk EI; Samygin VM; Ruban NM
    Mikrobiol Z; 2006; 68(1):33-40. PubMed ID: 16686216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances and remaining uncertainties in the epidemiology of Burkholderia pseudomallei and melioidosis.
    Currie BJ
    Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):225-7. PubMed ID: 18166205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mviN homolog in Burkholderia pseudomallei is essential for viability and virulence.
    Ling JM; Moore RA; Surette MG; Woods DE
    Can J Microbiol; 2006 Sep; 52(9):831-42. PubMed ID: 17110975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and clinical evaluation of a PCR assay targeting the metalloprotease gene (mprA) of B. pseudomallei.
    Neubauer H; Sprague LD; Joseph M; Tomaso H; Al Dahouk S; Witte A; Kinne J; Hensel A; Wernery R; Wernery U; Scholz HC
    Zoonoses Public Health; 2007; 54(1):44-50. PubMed ID: 17359446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Burkholderia mallei and Burkholderia pseudomallei as bioterrorism agents: national aspects of emergency preparedness.
    Gilad J; Harary I; Dushnitsky T; Schwartz D; Amsalem Y
    Isr Med Assoc J; 2007 Jul; 9(7):499-503. PubMed ID: 17710778
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of different Burkholderia pseudomallei isolates of varying levels of virulence on toll-like-receptor expression.
    Feterl M; Govan BL; Ketheesan N
    Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S82-8. PubMed ID: 19121695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type VI secretion is a major virulence determinant in Burkholderia mallei.
    Schell MA; Ulrich RL; Ribot WJ; Brueggemann EE; Hines HB; Chen D; Lipscomb L; Kim HS; Mrázek J; Nierman WC; Deshazer D
    Mol Microbiol; 2007 Jun; 64(6):1466-85. PubMed ID: 17555434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of tigecycline in the treatment of acute Burkholderia pseudomallei infection in a murine model.
    Feterl M; Govan B; Engler C; Norton R; Ketheesan N
    Int J Antimicrob Agents; 2006 Nov; 28(5):460-4. PubMed ID: 17046208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative in vivo and in vitro analyses of putative virulence factors of Burkholderia pseudomallei using lipopolysaccharide, capsule and flagellin mutants.
    Wikraiphat C; Charoensap J; Utaisincharoen P; Wongratanacheewin S; Taweechaisupapong S; Woods DE; Bolscher JG; Sirisinha S
    FEMS Immunol Med Microbiol; 2009 Aug; 56(3):253-9. PubMed ID: 19549172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A role of Burkholderia pseudomallei flagella as a virulent factor.
    Chuaygud T; Tungpradabkul S; Sirisinha S; Chua KL; Utaisincharoen P
    Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S140-4. PubMed ID: 19121676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative studies of the genus Malleomyces and selected Pseudomonas species. I. Morphological and cultural characteristics.
    WETMORE PW; GOCHENOUR WS
    J Bacteriol; 1956 Jul; 72(1):79-89. PubMed ID: 13345779
    [No Abstract]   [Full Text] [Related]  

  • 38. Altered proteome in Burkholderia pseudomallei rpoE operon knockout mutant: insights into mechanisms of rpoE operon in stress tolerance, survival, and virulence.
    Thongboonkerd V; Vanaporn M; Songtawee N; Kanlaya R; Sinchaikul S; Chen ST; Easton A; Chu K; Bancroft GJ; Korbsrisate S
    J Proteome Res; 2007 Apr; 6(4):1334-41. PubMed ID: 17346071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of a reporter system to study Burkholderia mallei type III secretion and identification of the BopA effector protein function in intracellular survival.
    Whitlock GC; Estes DM; Young GM; Young B; Torres AG
    Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S127-33. PubMed ID: 19121674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic patterns of pathogen evolution revealed by comparison of Burkholderia pseudomallei, the causative agent of melioidosis, to avirulent Burkholderia thailandensis.
    Yu Y; Kim HS; Chua HH; Lin CH; Sim SH; Lin D; Derr A; Engels R; DeShazer D; Birren B; Nierman WC; Tan P
    BMC Microbiol; 2006 May; 6():46. PubMed ID: 16725056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.